Ambrosia Biosciences
Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders.
$100MSeries B
LeadBO
Blue Owl Healthcare Opportunities
Activity from announced rounds
Activity in this selectionAI
- Rounds participated in
- 1
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $100M 1 disclosed · full round size, not this investor’s share